11 – 20 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe : an ERA Registry study
- Contribution to journal › Article
-
Mark
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
- Contribution to journal › Scientific review
-
Mark
Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19
- Contribution to journal › Article
-
Mark
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
- Contribution to journal › Article
-
Mark
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis
- Contribution to journal › Article
- 2022
-
Mark
The management of membranous nephropathy—an update
- Contribution to journal › Article
-
Mark
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases : consensus statements from the ERA-IWG and EUVAS
- Contribution to journal › Scientific review
- 2021
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
- Contribution to journal › Letter
- 2020
-
Mark
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
- Contribution to journal › Article
- 2018
-
Mark
High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4 : Results of a 12-week double-blind, randomized, controlled study
- Contribution to journal › Article
